• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Eli Lilly licenses non opioid pain med for $40M upfront

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 02, 2023 at 10:02: AM
via Belgium-based Confo Therapeutics announced a licensing agreement with Eli Lilly (NYSE:LLY) on Wednesday to grant the pharma giant global rights for its experimental non-opioid pain therapy CFTX-1554 for $40M upfront.

article source
 




Top Bottom
Back
Quote